Akcea Therapeutics, Inc. Proceeds from Common Stock Issued
Akcea Therapeutics, Inc. reported Proceeds from Common Stock Issued of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2020-03-02
- Akcea Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2017-12-31 was $0.00.
- Akcea Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2017 was $135.44M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $135.44M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $135.44M 10-Q · filed 2018-11-06 |